Adrenergic Cholinergic Enteric Measures/Mapping

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients seen who had autonomic and enteric profiling (Adrenergic, Cholinergic, Enteric Measures/Mapping=ACEM\_ from 2012-2019 at the University of Louisville.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

NCT04669548

Intraabdominal Hypertension Abdominal Compartment Syndrome Acute Kidney Injury +1 more

RECRUITING

Physiologic Signals and Signatures With the Accuryn Monitoring System (The Accuryn Registry)

NCT04585555

Acute Kidney Injury Abdominal Compartment Syndrome Intraabdominal Hypertension +1 more

COMPLETED

Physiologic Signals and Signatures With the Accuryn™ Monitoring System in Intensive Care Patients

NCT02602782

Critical Care, Intensive Care

COMPLETED

SpO2 System Accuracy Testing With Different Sensors

NCT01613222

Pulse Oximetry

COMPLETED NA

Cardiac Monitor Employee Study

NCT03826225

Arrhythmias, Cardiac

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Patients seen who had autonomic and enteric profiling (Adrenergic Cholinergic Enteric Measures/Mapping=ACEM) from 2012-2019 at the U of Louisville.
2. Results of the physiologic measures of ACEM had the results recorded.
3. ACEM is compared to standardized gastric emptying values as the primary measure.
4. ACEM is also compared to metabolic measures of weight, height and thus BMI as a secondary measure.
5. ACEM is aloes compared with standardized gastrointestinal symptoms by a traditional patient recorded outcome as another secondary measure.

Other sites may be added if they have identical IRB and/or data sharing agreements with the University of Louisville.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with the symptoms suggestive of autonomic and/or enteric disorders.

Exclusion Criteria

* Anatomic obstruction of the GI tract
* Pregnancy
* Inability of patient or guardian to sign informed consent, if needed
* Psychiatric disorders precluding assessment and treatment of the patient's GI condition.

Minimum Eligible Age

10 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No